| Name | Title | Contact Details |
|---|
Achieve Healthcare is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Achieve Healthcare is based in Eden Prairie, MN. You can find more information on Achieve Healthcare at www.achievehealthcare.com
Eastern Ct Health Network is a Manchester, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We bring many years of combined experience of equipment support, on-staff hospital imaging engineering and operations into a top-notch group of service and sales professionals. In-depth knowledge and customer focus is key. We handle all types of MRI and CT maintenance and services, including full system installation, rigging, de-installation, cold-head replacement and cryogen fills. These are just some of the reasons why leading hospitals and physician groups rely on East Coast Medical Systems to repair and service their imaging equipment.Our purpose is to express our diligence, knowledge and vigilance by pinpointing our customer`s needs and by addressing their problems, by hiring highly skilled engineers in order to provide an exact diagnosis and by being keenly watchful for any ensuing problems. To grow the organization properly, and maintain our reputation as being one of the highest regarded companies in our field, both by our customers and our peers.
It is the vision of Willow Crest hospital to be the provider of choice for patients, family members, and referral sources. We shall strive to exceed expectations of our customers in the provision of high quality, cost effective services.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.